3 results
Approved WMOCompleted
Study phase A: Prospective Data CollectionObjectives: * What is the time weighted average spent in hypotension (defined as MAP<65 mmHg) during surgery? * What is normal treatment behaviour of hypotension during surgery? (Treatment choice,…
Approved WMORecruiting
To assesses the efficacy of Tinlarebant in slowing the rate of growth of atrophic lesion(s) in adolescent subjects with STGD1.
Approved WMORecruiting
The purpose of this study is to characterize the safety and tolerability of OAV101 IT in participants who have discontinued treatment with nusinersen (Spinraza®) or risdiplam (Evrysdi®). The data from this study will expand on the data generated…